NCT02064231

Brief Summary

To assess the functionality and safety of the test products and also assess the products ability to collect stool without interfering with the stoma.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2012

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

February 13, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 17, 2014

Completed
2 months until next milestone

Results Posted

Study results publicly available

April 4, 2014

Completed
Last Updated

September 10, 2020

Status Verified

August 1, 2020

Enrollment Period

2 months

First QC Date

February 13, 2014

Results QC Date

February 25, 2014

Last Update Submit

August 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Degree of Leakage

    Degree of leakage is measured on a 24 point scale where 0 represents no leakage (best possible outcome) and 24 represents leakage on the whole plate (worst possible outcome).

    14 days

Study Arms (2)

Coloplast Test A, Coloplast Test B, Own product

EXPERIMENTAL

The subjects first test Coloplast Test A and thereafter Coloplast Test B and finally their own product for 14 days

Device: Coloplast Test ADevice: Coloplast Test BDevice: Own product

Coloplast Test C , Coloplast Test D, Own product

EXPERIMENTAL

The subjects first test Coloplast Test C and thereafter Coloplast Test D and finally their own product for 14 days

Device: Own productDevice: Coloplast Test CDevice: Coloplast Test D

Interventions

Coloplast Test A is a new ostomy appliance developed by Coloplast A/S

Coloplast Test A, Coloplast Test B, Own product

Coloplast Test B is a newly developed ostomy appliance developed by Coloplast A/S

Coloplast Test A, Coloplast Test B, Own product

Own product is tested to get baseline results. Own product can be any 2-piece product that is commercially available. The manufactures can be Coloplast, Hollister, Convatec, Dansac, B. Braun and others.

Coloplast Test A, Coloplast Test B, Own productColoplast Test C , Coloplast Test D, Own product

Coloplast Test C is a new ostomy appliance developed by Coloplast A/S

Coloplast Test C , Coloplast Test D, Own product

Coloplast Test D is a new ostomy appliance developed by Coloplast A/S

Coloplast Test C , Coloplast Test D, Own product

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Had given written informed consent
  • Was at least 18 years of age
  • Was able to handle the appliances themselves or with help from a caregiver (e.g. spouse)
  • Had an ileostomy with a diameter between 15-45 mm
  • Have had an ileostomy for at least 3 months
  • Currently used a 2-piece flat appliance

You may not qualify if:

  • Used irrigation during the investigation (flush stoma with water)
  • Currently received or had within the past 2 months received radio- and/or chemotherapy.
  • Currently received or had within the past month received local or systemic steroid treatment in the peristomal area.
  • Was pregnant or breast feeding
  • Participated in other interventional studies that could interfere with this one or had previously participated in this investigation.
  • Had a baseplate wear time of more than three days
  • Suffered from peristomal skin problems that precluded participation in the investigation (assessed by the investigation nurse)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Results Point of Contact

Title
Birte Petersen Jakobsen, MD
Organization
Coloplast A/S

Study Officials

  • Birte p Jakobsen, MD

    Medical director

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2014

First Posted

February 17, 2014

Study Start

June 1, 2012

Primary Completion

August 1, 2012

Study Completion

August 1, 2012

Last Updated

September 10, 2020

Results First Posted

April 4, 2014

Record last verified: 2020-08